2024 Q2 Form 10-Q Financial Statement
#000181949324000101 Filed on May 15, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| Revenue | $15.54M | $13.16M | $4.697M |
| YoY Change | 226.78% | 180.22% | -33.2% |
| Cost Of Revenue | $13.51M | $10.37M | $5.574M |
| YoY Change | 59.28% | 86.11% | -45.28% |
| Gross Profit | $2.030M | $2.788M | -$877.0K |
| YoY Change | -154.5% | -417.9% | -72.2% |
| Gross Profit Margin | 13.07% | 21.18% | -18.67% |
| Selling, General & Admin | $10.40M | $9.957M | $13.40M |
| YoY Change | -10.17% | -25.71% | 49.3% |
| % of Gross Profit | 512.32% | 357.14% | |
| Research & Development | $2.998M | $3.074M | $5.749M |
| YoY Change | -42.13% | -46.53% | -49.22% |
| % of Gross Profit | 147.68% | 110.26% | |
| Depreciation & Amortization | $900.0K | $900.0K | $1.000M |
| YoY Change | 125.0% | -10.0% | 233.33% |
| % of Gross Profit | 44.33% | 32.28% | |
| Operating Expenses | $13.40M | $13.03M | $19.15M |
| YoY Change | -20.05% | -31.96% | -5.65% |
| Operating Profit | -$11.37M | -$10.24M | -$20.03M |
| YoY Change | -44.5% | -48.86% | -14.6% |
| Interest Expense | -$372.0K | -$768.0K | -$2.997M |
| YoY Change | -87.97% | -74.37% | 548.7% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $1.545M | -$584.0K | -$4.151M |
| YoY Change | -138.99% | -85.93% | -5224.69% |
| Pretax Income | -$9.659M | -$11.00M | -$24.33M |
| YoY Change | -59.03% | -54.79% | 14.85% |
| Income Tax | $4.000K | $5.000K | $2.000K |
| % Of Pretax Income | |||
| Net Earnings | -$9.663M | -$11.00M | -$24.33M |
| YoY Change | -59.02% | -54.78% | 14.84% |
| Net Earnings / Revenue | -62.2% | -83.6% | -518.01% |
| Basic Earnings Per Share | -$1.23 | -$1.80 | -$0.14 |
| Diluted Earnings Per Share | -$1.23 | -$1.80 | -$0.14 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 7.873M shares | 7.750M shares | 169.0M shares |
| Diluted Shares Outstanding | 7.864M shares | 6.108M shares | 168.8M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $19.66M | $46.17M | $64.02M |
| YoY Change | -52.23% | -27.88% | -37.01% |
| Cash & Equivalents | $19.70M | $46.20M | $36.49M |
| Short-Term Investments | $27.53M | ||
| Other Short-Term Assets | $9.050M | $9.292M | $7.344M |
| YoY Change | 33.46% | 26.53% | -57.8% |
| Inventory | $41.36M | $36.62M | $57.01M |
| Prepaid Expenses | |||
| Receivables | $29.74M | $20.32M | $6.970M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $100.1M | $112.8M | $136.5M |
| YoY Change | -9.61% | -17.34% | -19.43% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $17.17M | $18.23M | $23.92M |
| YoY Change | -22.41% | -23.82% | 32.78% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $6.145M | $3.954M | $1.821M |
| YoY Change | 284.3% | 117.13% | 259.88% |
| Total Long-Term Assets | $23.31M | $22.18M | $25.75M |
| YoY Change | -1.74% | -13.85% | -44.74% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $100.1M | $112.8M | $136.5M |
| Total Long-Term Assets | $23.31M | $22.18M | $25.75M |
| Total Assets | $123.4M | $135.0M | $162.2M |
| YoY Change | -8.22% | -16.79% | -24.89% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.097M | $2.272M | $3.533M |
| YoY Change | 33.26% | -35.69% | -55.51% |
| Accrued Expenses | $7.841M | $10.43M | $7.232M |
| YoY Change | 5.45% | 44.19% | 604.87% |
| Deferred Revenue | $279.0K | $332.0K | $764.0K |
| YoY Change | -72.4% | -56.54% | -90.59% |
| Short-Term Debt | $1.341M | $690.0K | $2.824M |
| YoY Change | -2.4% | -75.57% | |
| Long-Term Debt Due | $1.945M | $2.046M | $21.76M |
| YoY Change | -89.27% | -90.6% | 4314.4% |
| Total Short-Term Liabilities | $20.05M | $22.31M | $40.83M |
| YoY Change | -41.92% | -45.38% | 106.25% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $20.41M | $20.88M | $23.44M |
| YoY Change | -10.92% | -10.94% | 1420.23% |
| Other Long-Term Liabilities | $23.77M | $24.33M | $10.47M |
| YoY Change | 139.52% | 132.46% | -74.61% |
| Total Long-Term Liabilities | $23.77M | $24.33M | $10.47M |
| YoY Change | 139.52% | 132.46% | -75.52% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $20.05M | $22.31M | $40.83M |
| Total Long-Term Liabilities | $23.77M | $24.33M | $10.47M |
| Total Liabilities | $64.21M | $67.17M | $72.46M |
| YoY Change | -1.57% | -7.3% | 15.83% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$173.9M | -$164.3M | -$101.7M |
| YoY Change | 38.78% | 61.44% | 302.5% |
| Common Stock | $1.000K | $1.000K | $17.00K |
| YoY Change | -94.12% | -94.12% | 6.25% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $59.22M | $67.81M | $89.75M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $123.4M | $135.0M | $162.2M |
| YoY Change | -8.22% | -16.79% | -24.89% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$9.663M | -$11.00M | -$24.33M |
| YoY Change | -59.02% | -54.78% | 14.84% |
| Depreciation, Depletion And Amortization | $900.0K | $900.0K | $1.000M |
| YoY Change | 125.0% | -10.0% | 233.33% |
| Cash From Operating Activities | -$25.99M | -$14.60M | -$15.33M |
| YoY Change | 76.59% | -4.74% | -51.04% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $126.0K | $30.00K | $253.0K |
| YoY Change | -88.56% | -88.14% | -91.56% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $51.36M | $23.07M |
| YoY Change | -100.0% | 122.65% | -23.5% |
| Cash From Investing Activities | -$126.0K | $51.33M | $22.81M |
| YoY Change | -100.91% | 124.99% | -15.99% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -484.0K | -$1.093M | -$9.672M |
| YoY Change | -93.77% | -88.7% | 5243.65% |
| NET CHANGE | |||
| Cash From Operating Activities | -25.99M | -$14.60M | -$15.33M |
| Cash From Investing Activities | -126.0K | $51.33M | $22.81M |
| Cash From Financing Activities | -484.0K | -$1.093M | -$9.672M |
| Net Change In Cash | -26.60M | $35.64M | -$2.186M |
| YoY Change | 206.24% | -1730.51% | -49.54% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$25.99M | -$14.60M | -$15.33M |
| Capital Expenditures | $126.0K | $30.00K | $253.0K |
| Free Cash Flow | -$26.11M | -$14.63M | -$15.58M |
| YoY Change | 65.09% | -6.09% | -54.58% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0333 | |
| CY2023Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0333 | |
| CY2023Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0333 | |
| CY2023Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0333 | |
| CY2023Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0333 | |
| CY2023Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.0333 | |
| CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5941000 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5941000 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
10374000 | usd |
| CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
5574000 | usd |
| CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
2788000 | usd |
| CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
-877000 | usd |
| CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8959000 | usd |
| CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11599000 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
3074000 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5749000 | usd |
| CY2024Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
998000 | usd |
| CY2023Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1804000 | usd |
| CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
13031000 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
19152000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10243000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-20029000 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-584000 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4151000 | usd |
| CY2024Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-168000 | usd |
| CY2023Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-97000 | usd |
| CY2024Q1 | xos |
Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
|
3000 | usd |
| CY2023Q1 | xos |
Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
|
52000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10998000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-24329000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
5000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11003000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24331000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
|
0 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
|
0 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
|
0 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
|
402000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11003000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-23929000 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.80 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.32 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.80 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-4.32 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6108000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5628000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6108000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5628000 | shares |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
112075000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1987000 | usd |
| CY2023Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
382000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-23929000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
89751000 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
45196000 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1968000 | usd |
| CY2024Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
258000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
31856000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
47000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11003000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11003000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24331000 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
913000 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
1000000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
404000 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
383000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
12000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
1798000 | usd |
| CY2024Q1 | xos |
Amortization Of Insurance Premiums
AmortizationOfInsurancePremiums
|
725000 | usd |
| CY2023Q1 | xos |
Amortization Of Insurance Premiums
AmortizationOfInsurancePremiums
|
1218000 | usd |
| CY2024Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
-803000 | usd |
| CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
-471000 | usd |
| CY2024Q1 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
0 | usd |
| CY2023Q1 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
1039000 | usd |
| CY2024Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-168000 | usd |
| CY2023Q1 | us-gaap |
Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
|
-97000 | usd |
| CY2024Q1 | xos |
Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
|
3000 | usd |
| CY2023Q1 | xos |
Derivative Instrument Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability
|
52000 | usd |
| CY2024Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
0 | usd |
| CY2023Q1 | us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
-91000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2006000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2012000 | usd |
| CY2024Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-430000 | usd |
| CY2023Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
475000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5198000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1268000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-2110000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1064000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1104000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1791000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-120000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
222000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1272000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
635000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-2100000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1307000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-14589000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-15326000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
30000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
253000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
0 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
23065000 | usd |
| CY2024Q1 | xos |
Cash Acquired From Asset Acquisition
CashAcquiredFromAssetAcquisition
|
51355000 | usd |
| CY2023Q1 | xos |
Cash Acquired From Asset Acquisition
CashAcquiredFromAssetAcquisition
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
51325000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
22812000 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
569000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
600000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
451000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
2187000 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
764000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
1427000 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
9450000 | usd |
| CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
258000 | usd |
| CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
382000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
47000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1093000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-9672000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
35643000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2186000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11640000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
38675000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
47283000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
36489000 | usd |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
46168000 | usd |
| CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
36489000 | usd |
| CY2024Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
1115000 | usd |
| CY2023Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
0 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
47283000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
36489000 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
| CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
36600000 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
980000 | usd |
| CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
16000 | usd |
| CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd |
| CY2024Q1 | xos |
Increase Decrease In Capital Expenditures Accrual
IncreaseDecreaseInCapitalExpendituresAccrual
|
-16000 | usd |
| CY2023Q1 | xos |
Increase Decrease In Capital Expenditures Accrual
IncreaseDecreaseInCapitalExpendituresAccrual
|
2000 | usd |
| CY2024Q1 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
54630000 | usd |
| CY2023Q1 | us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
0 | usd |
| CY2024Q1 | us-gaap |
Stock Issued1
StockIssued1
|
31856000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued1
StockIssued1
|
0 | usd |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
46200000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-14600000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-15300000 | usd |
| CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-39300000 | usd |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenues and expenses during the reporting periods. The areas with significant estimates and judgments include, among others, inventory valuation, incremental borrowing rates for assessing operating and financing lease liabilities, useful lives of property and equipment, stock-based compensation, product warranty liability, and valuation of convertible debt and related embedded derivatives, common stock warrant liability and earn-out shares liability. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to the Company’s financial statements.</span></div> | |
| CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
82000 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
62000 | usd |
| CY2023Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1306000 | usd |
| CY2022Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1099000 | usd |
| CY2024Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
522000 | usd |
| CY2023Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
216000 | usd |
| CY2024Q1 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
415000 | usd |
| CY2023Q1 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
272000 | usd |
| CY2024Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1199000 | usd |
| CY2023Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
1155000 | usd |
| CY2024Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit and Business Risk</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of March 31, 2024 and 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></div> | |
| CY2024Q1 | xos |
Defined Contribution Plan Auto Enrollment Contributions Per Employee Percent
DefinedContributionPlanAutoEnrollmentContributionsPerEmployeePercent
|
0.03 | |
| CY2024Q1 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
0 | usd |
| CY2023Q1 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
0 | usd |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
12635000 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4433000 | usd |
| CY2024Q1 | us-gaap |
Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
|
527000 | usd |
| CY2023Q1 | us-gaap |
Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
|
264000 | usd |
| CY2024Q1 | us-gaap |
Revenues
Revenues
|
13162000 | usd |
| CY2023Q1 | us-gaap |
Revenues
Revenues
|
4697000 | usd |
| CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2024Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
2000000 | usd |
| CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
37800000 | usd |
| CY2024Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
29498000 | usd |
| CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
30357000 | usd |
| CY2024Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
4169000 | usd |
| CY2023Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
3033000 | usd |
| CY2024Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
2954000 | usd |
| CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
4453000 | usd |
| CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
36621000 | usd |
| CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
37843000 | usd |
| CY2024Q1 | xos |
Prepaid Inventory
PrepaidInventory
|
2473000 | usd |
| CY2023Q4 | xos |
Prepaid Inventory
PrepaidInventory
|
1745000 | usd |
| CY2024Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
4328000 | usd |
| CY2023Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
2796000 | usd |
| CY2024Q1 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
400000 | usd |
| CY2023Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
811000 | usd |
| CY2024Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
968000 | usd |
| CY2023Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
1310000 | usd |
| CY2024Q1 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
408000 | usd |
| CY2023Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
408000 | usd |
| CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
8577000 | usd |
| CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
7070000 | usd |
| CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
10428000 | usd |
| CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
7435000 | usd |
| CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
332000 | usd |
| CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
690000 | usd |
| CY2024Q1 | xos |
Deposits Of Customers Current
DepositsOfCustomersCurrent
|
2113000 | usd |
| CY2023Q4 | xos |
Deposits Of Customers Current
DepositsOfCustomersCurrent
|
2364000 | usd |
| CY2024Q1 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
1199000 | usd |
| CY2023Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
1306000 | usd |
| CY2024Q1 | us-gaap |
Notes Payable
NotesPayable
|
363000 | usd |
| CY2023Q4 | us-gaap |
Notes Payable
NotesPayable
|
350000 | usd |
| CY2024Q1 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
690000 | usd |
| CY2023Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
1003000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
2862000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1664000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
2046000 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
2005000 | usd |
| CY2024Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
20033000 | usd |
| CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
16817000 | usd |
| CY2024Q1 | xos |
Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
|
300000 | usd |
| CY2023Q1 | xos |
Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
|
200000 | usd |
| CY2023 | xos |
Contract With Customer Liability Revenue Recognized Including Opening Balance
ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance
|
400000 | usd |
| CY2024Q1 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
3777000 | usd |
| CY2023Q4 | us-gaap |
Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
|
2985000 | usd |
| CY2024Q1 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
497000 | usd |
| CY2023Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
593000 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
19113000 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3511000 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
945000 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
1472000 | usd |
| CY2024Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
24332000 | usd |
| CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
8561000 | usd |
| CY2021Q3 | xos |
Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
|
540000 | shares |
| CY2024Q1 | xos |
Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
|
42000 | usd |
| CY2023Q4 | xos |
Derivative Instrument Contingent Consideration Liability
DerivativeInstrumentContingentConsiderationLiability
|
39000 | usd |
| CY2024Q1 | xos |
Derivative Instrument Gain Loss Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentGainLossChangeInAmountOfContingentConsiderationLiability
|
-3000 | usd |
| CY2023Q1 | xos |
Derivative Instrument Gain Loss Change In Amount Of Contingent Consideration Liability
DerivativeInstrumentGainLossChangeInAmountOfContingentConsiderationLiability
|
-52000 | usd |
| CY2022Q3 | xos |
Debt Instrument Convertible Redemption Notice Period
DebtInstrumentConvertibleRedemptionNoticePeriod
|
P10D | |
| CY2024Q1 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | usd |
| CY2023Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | usd |
| CY2022Q3 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
20000000 | usd |
| CY2022Q3 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
20000000 | usd |
| CY2024Q1 | xos |
Capital Stock Shares Authorized
CapitalStockSharesAuthorized
|
1010000000 | shares |
| CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
| CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2024Q1 | xos |
Common Stock Voting Rights Number Of Votes
CommonStockVotingRightsNumberOfVotes
|
1 | vote |
| CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1000000000 | shares |
| CY2024Q1 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
5500 | shares |
| CY2023Q1 | us-gaap |
Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
|
0 | shares |
| CY2024Q1 | us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
46750 | usd |
| CY2023Q1 | us-gaap |
Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
|
0 | usd |
| CY2024Q1 | xos |
Sale Of Stock Remaining Commitment Amount Available
SaleOfStockRemainingCommitmentAmountAvailable
|
119500000 | usd |
| CY2023Q4 | xos |
Sale Of Stock Remaining Commitment Amount Available
SaleOfStockRemainingCommitmentAmountAvailable
|
119500000 | usd |
| CY2024Q1 | xos |
Class Of Warrant Or Right Fair Market Value Threshold Consecutive Trading Days Ending On Third Trading Day Prior To Notice Of Redemption
ClassOfWarrantOrRightFairMarketValueThresholdConsecutiveTradingDaysEndingOnThirdTradingDayPriorToNoticeOfRedemption
|
P10D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1853000 | shares |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
22512000 | shares |
| CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.40 | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.51 | |
| CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P0Y6M18D | |
| CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
168194 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
20659000 | shares |
| CY2024Q1 | xos |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
|
0.38 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.50 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
141076 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1853000 | shares |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.56 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.63 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y9M14D | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
17806 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1654000 | shares |
| CY2024Q1 | xos |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableWeightedAverageGrantDateFairValue
|
0.54 | |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.64 | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y8M19D | |
| CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
15874 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
141076 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
800 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2000000 | usd |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2000000 | usd |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2006000 | usd |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2012000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
8000000 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y2M15D | |
| CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
22676000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
22662000 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
9038000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
8002000 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
13638000 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
14660000 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
900000 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
1000000 | usd |
| CY2024Q1 | xos |
Unrecorded Unconditional Purchase Obligation Number Of Vendors
UnrecordedUnconditionalPurchaseObligationNumberOfVendors
|
2 | vendor |
| CY2024Q1 | us-gaap |
Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
|
700000 | usd |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0004 | |
| CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.0001 | |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11003000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24331000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-11003000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-24331000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-11003000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-24331000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6108000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5628000 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.80 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.32 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6108000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5628000 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.80 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-4.32 |
